Zurueck zur Suche

Reporte zur Charge UT7718BA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

6Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
PR 2 ME 1 FL 1 RI 1 PA 1

VAERS 2488545

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge ut7718ba

moderat
Staat
ME
Alter
66,0
Geschlecht
M
Eingang
25.10.2022
Impfdatum
05.10.2022
Beginn
06.10.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Mobility decreased Pain in extremity Sleep disorder

Symptomtext

about a day or 2 later after the fluzone hd the patient arm started to ache. It is affecting the mobility of the arm and affected his sleep. He says he gets some relief when he put a pillow under his arm to sleep. this ache has been going on for at least 10 days at this point.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
non
Aktuelle Erkrankungen
none
Vorgeschichte
chronic pain amputation
Andere Medikamente
morhine 100mg er/ morphine 60 er, oxycodone 10, lisinpril 40/ atenolol 50mg, zolpidem 10mg, tamsulosin 0.4mg
Allergien
penicillin,
Vorherige Impfungen
-

VAERS 2466909

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7718BA

mild
Staat
PR
Alter
75,0
Geschlecht
F
Eingang
02.10.2022
Impfdatum
02.10.2022
Beginn
02.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Eye pruritus Inflammation Oropharyngeal discomfort Pruritus Pyrexia Rhinorrhoea

Symptomtext

Throat inflammation, fever, runny nose, itching in skin and eyes

Weitere VAERSDATA-Felder
Praegender Schweregrund
Eye pruritus
Hospital-Tage
-
Labordaten
Patient referred she only took two tylenol 500mg tablet at night. The morning after she was Ok.
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
none
Vorherige Impfungen
-

VAERS 2487302

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7718BA

gering
Staat
FL
Alter
62,0
Geschlecht
M
Eingang
24.10.2022
Impfdatum
04.10.2022
Beginn
04.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered No adverse event

Symptomtext

Wrong dosage given. No adverse reaction noted

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Arachnoid Cysts. Arthritis. GERD.
Andere Medikamente
?Sudafed 30 mg tablet 1 tab(s) orally PRN ?CeleBREX 200 mg capsule 1 cap(s) orally once a day ?diclofenac sodium 50 mg delayed release tablet 1 tab(s) orally 3 times a day ?bisoprolol 5 mg tablet 1 tab(s) orally once a day ?rano
Allergien
penicillin tetracycline
Vorherige Impfungen
-

VAERS 2484206

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7718BA

gering
Staat
RI
Alter
59,0
Geschlecht
M
Eingang
20.10.2022
Impfdatum
20.10.2022
Beginn
20.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

The patient received Fluzone HD which is indicated for patients age 65+. The patient is 59.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2483761

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7718BA

gering
Staat
PA
Alter
-
Geschlecht
U
Eingang
20.10.2022
Impfdatum
18.09.2022
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Memory impairment

Symptomtext

received FLUZONE HIGH DOSE QUADRIVALENT on 18SEP2022 then received another dose of it today; forgotten; Initial information received on 12-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an unknown age and unknown gender patient who experienced received fluzone high dose quadrivalent on 18sep2022 then received another dose of it today and forgotten while receiving vaccine influenza quadrival a-b high dose hv vaccine [fluzone high-dose quadrivalent]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 18-Sep-2022, the patient received a 2 dose of suspect influenza quadrival a-b high dose hv vaccine [fluzone high-dose quadrivalent] lot UT7718BA Expiration Date: 30-Jun-2023 via unknown route in unknown administration site for Immunization. On an unknown date the patient developed a non-serious received fluzone high dose quadrivalent on 18-sep-2022 then received another dose of it today (extra dose administered) and non-serious forgotten (memory impairment) (unknown latency) following the administration of vaccine influenza quadrival a-b high dose hv vaccine. It was reported "MA reporting that a patient received FLUZONE HIGH DOSE QUADRIVALENT on 18SEP2022 then received another dose of it today. MA said the patient must have forgotten that they already received the vaccine. MA requesting for guidance moving forward". Action taken: not applicable. It was not reported if the patient received a corrective treatment for the events. At time of reporting, the outcome was Unknown for the event received fluzone high dose quadrivalent on 18sep2022 then received another dose of it today and was Unknown for the event forgotten. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2469497

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7718BA

gering
Staat
PR
Alter
44,0
Geschlecht
F
Eingang
05.10.2022
Impfdatum
27.09.2022
Beginn
27.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

administered FLUZONE HD to a 44 yr old female with no adverse event; Initial information received on 28-Sep-2022 regarding an unsolicited valid non-serious case via pharmacist. This case involves a 44 years old female patient who was administered influenza quadrival A-B HIGH dose HV vaccine [fluzone high-dose quadrivalent] with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On 27-Sep-2022, the patient received suspect influenza quadrival A-B HIGH dose HV vaccine at an unknown dose (lot UT7718BA, expiry date: 30-Jun-2023) via unknown route in unknown administration site for immunisation. On 27-SEP-2022 influenza quadrival A-B HIGH dose HV vaccine was administered to a 44 year old female with no adverse event (product administered to patient of inappropriate age, latency: same day). They stated the patient had been contacted and they feel fine. They would like to know if there were any recommendations on what to do in this scenario. Action taken: Not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-